Published in Obstet Gynecol on April 01, 1982
Abdominal adiposity and hot flashes among midlife women. Menopause (2008) 2.65
Physical activity and change in quality of life during menopause--an 8-year follow-up study. Health Qual Life Outcomes (2012) 1.15
Differential association of modifiable health behaviors with hot flashes in perimenopausal and postmenopausal women. J Gen Intern Med (2004) 1.13
Genetic polymorphisms, hormone levels, and hot flashes in midlife women. Maturitas (2006) 1.02
Adiposity and hot flashes in midlife women: a modifying role of age. J Clin Endocrinol Metab (2011) 0.98
Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women's health study. J Womens Health (Larchmt) (2013) 0.95
Cigarette smoking, androgen levels, and hot flushes in midlife women. Obstet Gynecol (2008) 0.93
Relationship between menopausal symptoms and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 0.93
Endogenous hormones, participant characteristics, and symptoms among midlife women. Maturitas (2008) 0.85
Vasomotor symptoms in infertile premenopausal women: a hitherto unappreciated risk for low bone mineral density. Fertil Steril (2008) 0.83
Sex hormone concentrations and the risk of breast cancer recurrence in postmenopausal women without hot flashes. Cancer Epidemiol Biomarkers Prev (2011) 0.82
Genetic polymorphisms in the aryl hydrocarbon receptor signaling pathway as potential risk factors of menopausal hot flashes. Am J Obstet Gynecol (2012) 0.81
Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ (1994) 0.81
Current alcohol use, hormone levels, and hot flashes in midlife women. Fertil Steril (2007) 0.78
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites. BMC Cancer (2013) 0.78
Estrogen replacement therapy. Can Fam Physician (1989) 0.75
[Prevention of secondary manifestations of menopause. Pathophysiologic principles]. Arch Gynecol Obstet (1989) 0.75
Low plasma PDGF-BB levels are associated with estradiol in postmenopausal osteoporosis. J Int Med Res (2017) 0.75
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med (1999) 2.63
Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril (1999) 2.52
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
Biologic effects of transdermal estradiol. N Engl J Med (1986) 2.24
Clinical L-type Ca(2+) channel blockade prevents ischemic preconditioning of human myocardium. J Mol Cell Cardiol (1999) 2.04
Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest (1986) 2.01
Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab (1983) 1.84
Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation (1997) 1.80
The abdominal compartment syndrome is a morbid complication of postinjury damage control surgery. Am J Surg (2001) 1.76
Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab (1974) 1.73
The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer (1988) 1.66
Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol (1999) 1.64
Cornual pregnancies in patients with prior salpingectomy undergoing in vitro fertilization and embryo transfer. Fertil Steril (1996) 1.60
Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst (1985) 1.60
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest (1976) 1.58
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis. J Clin Endocrinol Metab (1982) 1.57
The physiologic basis for anticytokine clinical trials in the treatment of sepsis. J Am Coll Surg (1998) 1.57
Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst (1986) 1.54
Do regular ovulatory cycles increase breast cancer risk? Cancer (1985) 1.50
Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol (1999) 1.48
Feasibility of damage control surgery in the management of military combat casualties. Arch Surg (2000) 1.45
Impotence in scleroderma. Ann Intern Med (1986) 1.44
Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol (1987) 1.42
Response to Slotnich and ortega [Monoamniotic twinning and zone manipulation: a survey of U.S. IVF centers correlating zona manipulation procedures and high-risk twinning frequency (J Assist Reprod Genet 1996; 13:381-385)]. J Assist Reprod Genet (1996) 1.39
Diastolic hibernation masquerading as constrictive pericarditis. J Card Surg (1998) 1.38
Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist. J Clin Endocrinol Metab (1983) 1.36
TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol (2004) 1.33
Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine (1990) 1.30
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol (1974) 1.29
Origin of serum estradiol in postmenopausal women. Obstet Gynecol (1982) 1.28
Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril (1991) 1.27
Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J Clin Endocrinol Metab (1980) 1.25
Estrogen replacement therapy. Obstet Gynecol (1981) 1.25
Influence of age and sex on plasma calcitonin in human beings. N Engl J Med (1980) 1.23
Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am J Obstet Gynecol (1980) 1.19
Dietary calcium intake and rates of bone loss in women. J Clin Invest (1987) 1.17
Early renal ischemia, with or without reperfusion, activates NFkappaB and increases TNF-alpha bioactivity in the kidney. J Urol (2000) 1.16
TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction. Am J Physiol Regul Integr Comp Physiol (2006) 1.16
A novel model of ischemia in renal tubular cells which closely parallels in vivo injury. J Surg Res (2001) 1.15
Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril (1991) 1.14
Estrogen replacement therapy: indications and complications. Ann Intern Med (1983) 1.11
Association of waking episodes with menopausal hot flushes. JAMA (1981) 1.09
LH, FSH and skin temperaure during the menopausal hot flash. J Clin Endocrinol Metab (1979) 1.08
Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol (1981) 1.06
Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol (1983) 1.05
Prenatal diagnosis of gall bladder anomalies--report of 17 cases. Prenat Diagn (1993) 1.05
Pituitary hormones during the menopausal hot flash. Obstet Gynecol (1984) 1.04
Serum 17 beta-estradiol and estrone levels in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab (1976) 1.03
The menopause: health implications and clinical management. J Am Geriatr Soc (1993) 1.03
Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. Am J Obstet Gynecol (1975) 1.02
Amniotic fluid testosterone levels in midpregnancy. Obstet Gynecol (1976) 1.01
LPS induces late cardiac functional protection against ischemia independent of cardiac and circulating TNF-alpha. Am J Physiol (1997) 1.00
Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors. Obstet Gynecol (1979) 1.00
A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril (1992) 1.00
TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol (1998) 1.00
Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int (1993) 0.98
Pulsatile patterns of gonadotropins and testosterone in man: the effects of clomiphene, with and without testosterone added. J Clin Endocrinol Metab (1973) 0.98
p38 MAPK inhibition decreases TNF-alpha production and enhances postischemic human myocardial function. J Surg Res (1999) 0.98
Amniotic fluid androgens and estrogens in midgestation. J Clin Endocrinol Metab (1977) 0.97
Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. Am J Physiol (1998) 0.97
Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism. Am J Obstet Gynecol (1977) 0.96
Prediagnostic serum hormones and the risk of prostate cancer. Cancer Res (1988) 0.96
Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab (1973) 0.96
Free estradiol in postmenopausal women with and without endometrial cancer. J Clin Endocrinol Metab (1981) 0.96
Cardioadaptation induced by cyclic ischemic preconditioning is mediated by translational regulation of de novo protein synthesis. J Surg Res (1997) 0.96
Biological effects of various doses of conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab (1980) 0.96
Endogenous cortisol and sex steroids in patients with osteoporotic spinal fractures. Obstet Gynecol (1983) 0.95
Objective techniques for the assessment of postmenopausal hot flashes. Obstet Gynecol (1981) 0.95
p38 MAPK mediates renal tubular cell TNF-alpha production and TNF-alpha-dependent apoptosis during simulated ischemia. Am J Physiol Cell Physiol (2001) 0.95
LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent. J Surg Res (1999) 0.94
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. J Clin Endocrinol Metab (1992) 0.94
Capillary tube resistive thermal cycling. Anal Chem (1998) 0.94
Alterations in ovarian steroid and gonadotrophin secretion preceding the cessation of regular oestrous cycles in ageing female rats. J Endocrinol (1984) 0.94
Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist. J Clin Endocrinol Metab (1983) 0.94
Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab (1982) 0.94
A mechanism for the suppression of estrogen production in polycystic ovary syndrome. J Clin Endocrinol Metab (1996) 0.93
Hypogonadotropic hypogonadism associated with retinitis pigmentosa in a female sibship: evidence for gonadotropin deficiency. J Clin Endocrinol Metab (1981) 0.93
Objectively recorded hot flushes in patients with pituitary insufficiency. J Clin Endocrinol Metab (1981) 0.93
Preventive effects of transdermal 17 beta-estradiol on osteoporotic changes after surgical menopause: a two-year placebo-controlled trial. Am J Obstet Gynecol (1993) 0.92
The relation of ovarian steroid levels in young female rats to subsequent estrous cyclicity and reproductive function during aging. Biol Reprod (1986) 0.92
The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab (1984) 0.92
Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab (1984) 0.92
Preoperative localization of a testosterone-secreting ovarian tumor by retrograde venous catheterization and selective sampling. Am J Obstet Gynecol (1974) 0.92